Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Income Tax Expense

2.8 / 5 stars · 68/120 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Income Tax Expense

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Income Tax Expense of $53.93 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-05

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income tax expense (benefit) for the quarter ending 2026-06-27 was $53.93M, a 188.01% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income tax expense (benefit) for the quarter ending 2026-03-28 was -$15.14M, a 249.90% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income tax expense (benefit) for the quarter ending 2025-12-27 was -$17.81M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income tax expense (benefit) for the quarter ending 2025-09-27 was $31.64M, a 51.07% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income tax expense (benefit) for fiscal 2025 was $42.66M, a 37.10% decline from fiscal 2024.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income tax expense (benefit) for fiscal 2024 was $67.82M, a 32.79% decline from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income tax expense (benefit) for fiscal 2023 was $100.91M, a 22.60% decline from fiscal 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. income tax expense (benefit) for fiscal 2022 was $130.38M, a 59.25% increase from fiscal 2021.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 3 month as first filedIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 6 month as first filedIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 9 month as first filedIncome Tax Expense (Benefit) 12 month
2026-06-27$53.93M
10-Q · filed 2026-08-05
$38.79M
10-Q · filed 2026-08-05
$20.98M
derived: sum of 3 quarters · filed 2026-08-05
$52.63M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28-$15.14M
10-Q · filed 2026-05-07
-$32.95M
derived: sum of 2 quarters · filed 2026-05-07
-$1.30M
derived: sum of 3 quarters · filed 2026-05-07
$17.42M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-27-$17.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$13.84M
derived: sum of 2 quarters · filed 2026-02-18
$32.56M
derived: sum of 3 quarters · filed 2026-08-05
$42.66M
10-K · filed 2026-02-18
2025-09-27$31.64M
10-Q · filed 2025-11-05
$50.37M
derived: sum of 2 quarters · filed 2026-08-05
$60.47M
10-Q · filed 2025-11-05
$57.42M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28$18.73M
10-Q · filed 2026-08-05
$28.82M
10-Q · filed 2026-08-05
$25.78M
derived: sum of 3 quarters · filed 2026-08-05
$46.73M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$10.10M
10-Q · filed 2026-05-07
$7.06M
derived: sum of 2 quarters · filed 2026-05-07
$28.00M
derived: sum of 3 quarters · filed 2026-05-07
$53.39M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-28-$3.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$17.90M
derived: sum of 2 quarters · filed 2026-02-18
$43.29M
derived: sum of 3 quarters · filed 2026-02-18
$67.82M
10-K · filed 2026-02-18
2024-09-28$20.95M
10-Q · filed 2025-11-05
$46.34M
derived: sum of 2 quarters · filed 2025-11-05
$70.87M
10-Q · filed 2025-11-05
$90.62M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-29$25.39M
10-Q · filed 2025-08-06
$49.92M
10-Q · filed 2025-08-06
$69.67M
derived: sum of 3 quarters · filed 2026-02-18
$94.53M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-30$24.53M
10-Q · filed 2025-05-07
$44.28M
derived: sum of 2 quarters · filed 2026-02-18
$69.14M
derived: sum of 3 quarters · filed 2026-02-18
$98.36M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-30$19.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$44.61M
derived: sum of 2 quarters · filed 2026-02-18
$73.83M
derived: sum of 3 quarters · filed 2026-02-18
$100.91M
10-K · filed 2026-02-18
2023-09-30$24.85M
10-Q · filed 2024-11-06
$54.07M
derived: sum of 2 quarters · filed 2024-11-06
$81.16M
10-Q · filed 2024-11-06
$136.97M
derived: sum of 4 quarters · filed 2025-02-19
2023-07-01$29.22M
10-Q · filed 2024-08-07
$56.31M
10-Q · filed 2024-08-07
$112.12M
derived: sum of 3 quarters · filed 2025-02-19
$137.62M
derived: sum of 4 quarters · filed 2025-02-19
2023-04-01$27.09M
10-Q · filed 2024-05-09
$82.90M
derived: sum of 2 quarters · filed 2025-02-19
$108.40M
derived: sum of 3 quarters · filed 2025-02-19
$141.85M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31$55.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$81.31M
derived: sum of 2 quarters · filed 2025-02-19
$114.76M
derived: sum of 3 quarters · filed 2025-02-19
$130.38M
10-K · filed 2025-02-19
2022-09-24$25.50M
10-Q · filed 2023-11-08
$58.94M
derived: sum of 2 quarters · filed 2023-11-08
$74.56M
10-Q · filed 2023-11-08
$98.38M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-25$33.45M
10-Q · filed 2023-08-09
$49.07M
10-Q · filed 2023-08-09
$72.88M
derived: sum of 3 quarters · filed 2024-02-14
$91.00M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-26$15.62M
10-Q · filed 2023-05-11
$39.44M
derived: sum of 2 quarters · filed 2024-02-14
$57.55M
derived: sum of 3 quarters · filed 2024-02-14
$95.13M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-25$23.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$41.93M
derived: sum of 2 quarters · filed 2024-02-14
$79.51M
derived: sum of 3 quarters · filed 2024-02-14
$81.87M
10-K · filed 2024-02-14
2021-09-25$18.11M
10-Q · filed 2022-11-02
$55.69M
derived: sum of 2 quarters · filed 2022-11-02
$58.06M
10-Q · filed 2022-11-02
$86.30M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-26$37.58M
10-Q · filed 2022-08-03
$39.95M
10-Q · filed 2022-08-03
$68.18M
derived: sum of 3 quarters · filed 2023-02-22
$100.85M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-27$2.37M
10-Q · filed 2022-05-04
$30.60M
derived: sum of 2 quarters · filed 2023-02-22
$63.27M
derived: sum of 3 quarters · filed 2023-02-22
$79.55M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-26$28.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$60.90M
derived: sum of 2 quarters · filed 2023-02-22
$77.19M
derived: sum of 3 quarters · filed 2023-02-22
$81.81M
10-K · filed 2023-02-22
2020-09-26$32.66M
10-Q · filed 2021-11-03
$48.95M
derived: sum of 2 quarters · filed 2021-11-03
$53.57M
10-Q · filed 2021-11-03
$78.62M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-27$16.28M
10-Q · filed 2021-08-04
$20.91M
10-Q · filed 2021-08-04
$45.96M
derived: sum of 3 quarters · filed 2022-02-16
$45.64M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-28$4.62M
10-Q · filed 2021-05-04
$29.68M
derived: sum of 2 quarters · filed 2022-02-16
$29.36M
derived: sum of 3 quarters · filed 2022-02-16
$44.04M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-28$25.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$24.74M
derived: sum of 2 quarters · filed 2022-02-16
$39.42M
derived: sum of 3 quarters · filed 2022-02-16
$50.02M
10-K · filed 2022-02-16
2019-09-28-$317.00K
10-Q · filed 2020-10-29
$14.37M
derived: sum of 2 quarters · filed 2020-10-29
$24.97M
10-Q · filed 2020-10-29
$39.82M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-29$14.69M
10-Q · filed 2020-08-05
$25.29M
10-Q · filed 2020-08-05
$40.14M
derived: sum of 3 quarters · filed 2021-02-17
$52.54M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-30$10.60M
10-Q · filed 2020-05-07
$25.45M
derived: sum of 2 quarters · filed 2021-02-17
$37.85M
derived: sum of 3 quarters · filed 2021-02-17
$55.29M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-29$14.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$27.25M
derived: sum of 2 quarters · filed 2021-02-17
$44.69M
derived: sum of 3 quarters · filed 2021-02-17
$54.46M
10-K · filed 2021-02-17
2018-09-29$12.40M
10-Q · filed 2019-11-06
$29.84M
derived: sum of 2 quarters · filed 2019-11-06
$39.61M
10-Q · filed 2019-11-06
$137.71M
derived: sum of 4 quarters · filed 2020-02-11
2018-06-30$17.44M
10-Q · filed 2019-07-31
$27.21M
10-Q · filed 2019-07-31
$125.31M
derived: sum of 3 quarters · filed 2020-02-11
$145.25M
derived: sum of 4 quarters · filed 2020-02-11
2018-03-31$9.77M
10-Q · filed 2019-05-07
$107.87M
derived: sum of 2 quarters · filed 2020-02-11
$127.81M
derived: sum of 3 quarters · filed 2020-02-11
$150.06M
derived: sum of 4 quarters · filed 2020-02-11
2017-12-30$98.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11
$118.04M
derived: sum of 2 quarters · filed 2020-02-11
$140.28M
derived: sum of 3 quarters · filed 2020-02-11
$171.37M
10-K · filed 2020-02-11
2017-09-30$19.95M
10-Q · filed 2018-11-07
$42.19M
derived: sum of 2 quarters · filed 2018-11-07
$73.27M
10-Q · filed 2018-11-07
$91.72M
derived: sum of 4 quarters · filed 2019-02-13
2017-07-01$22.24M
10-Q · filed 2018-08-08
$53.33M
10-Q · filed 2018-08-08
$71.78M
derived: sum of 3 quarters · filed 2019-02-13
$87.34M
derived: sum of 4 quarters · filed 2019-02-13
2017-04-01$31.08M
10-Q · filed 2018-05-10
$49.53M
derived: sum of 2 quarters · filed 2019-02-13
$65.10M
derived: sum of 3 quarters · filed 2019-02-13
$83.94M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31$18.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$34.02M
derived: sum of 2 quarters · filed 2019-02-13
$52.86M
derived: sum of 3 quarters · filed 2019-02-13
$66.83M
10-K · filed 2019-02-13
2016-09-24$15.56M
10-Q · filed 2017-11-09
$34.41M
derived: sum of 2 quarters · filed 2017-11-09
$48.38M
10-Q · filed 2017-11-09
$65.11M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-25$18.84M
10-Q · filed 2017-08-09
$32.82M
10-Q · filed 2017-08-09
$49.55M
derived: sum of 3 quarters · filed 2018-02-13
$64.80M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-26$13.97M
10-Q · filed 2017-05-10
$30.70M
derived: sum of 2 quarters · filed 2018-02-13
$45.96M
derived: sum of 3 quarters · filed 2018-02-13
$57.03M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-26$16.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$31.98M
derived: sum of 2 quarters · filed 2018-02-13
$43.06M
derived: sum of 3 quarters · filed 2018-02-13
$43.39M
10-K · filed 2018-02-13
2015-09-26$15.26M
10-Q · filed 2016-11-02
$26.33M
derived: sum of 2 quarters · filed 2016-11-02
$26.66M
10-Q · filed 2016-11-02
$38.31M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-27$11.08M
10-Q · filed 2016-08-03
$11.41M
10-Q · filed 2016-08-03
$23.06M
derived: sum of 3 quarters · filed 2017-02-14
$34.64M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-28$331.00K
10-Q · filed 2016-05-04
$11.98M
derived: sum of 2 quarters · filed 2017-02-14
$23.56M
derived: sum of 3 quarters · filed 2017-02-14
$37.64M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-27$11.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$23.23M
derived: sum of 2 quarters · filed 2017-02-14
$37.31M
derived: sum of 3 quarters · filed 2017-02-14
$47.67M
10-K · filed 2017-02-14
2014-09-27$11.58M
10-Q · filed 2015-11-04
$25.66M
derived: sum of 2 quarters · filed 2015-11-04
$36.02M
10-Q · filed 2015-11-04
$39.60M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-28$14.08M
10-Q · filed 2015-07-30
$24.44M
10-Q · filed 2015-07-30
$28.02M
derived: sum of 3 quarters · filed 2016-02-12
$39.41M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-29$10.36M
10-Q · filed 2015-04-30
$13.94M
derived: sum of 2 quarters · filed 2016-02-12
$25.33M
derived: sum of 3 quarters · filed 2016-02-12
$33.55M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-28$3.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$14.97M
derived: sum of 2 quarters · filed 2016-02-12
$23.19M
derived: sum of 3 quarters · filed 2016-02-12
$32.91M
10-K · filed 2016-02-12
2013-09-28$11.39M
10-Q · filed 2014-10-30
$19.61M
derived: sum of 2 quarters · filed 2014-10-30
$29.33M
10-Q · filed 2014-10-30
$32.82M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-29$8.22M
10-Q · filed 2014-08-07
$17.94M
10-Q · filed 2014-08-07
$21.43M
derived: sum of 3 quarters · filed 2015-02-17
$27.44M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-30$9.72M
10-Q · filed 2014-04-30
$13.21M
derived: sum of 2 quarters · filed 2015-02-17
$19.22M
derived: sum of 3 quarters · filed 2015-02-17
$28.67M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-29$3.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
$9.50M
derived: sum of 2 quarters · filed 2015-02-17
$18.95M
derived: sum of 3 quarters · filed 2015-02-17
$27.63M
10-K · filed 2015-02-17
2012-09-29$6.01M
10-Q · filed 2013-10-30
$15.46M
derived: sum of 2 quarters · filed 2013-10-30
$24.14M
10-Q · filed 2013-10-30
$29.72M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$9.45M
10-Q · filed 2013-07-31
$18.13M
10-Q · filed 2013-07-31
$23.70M
derived: sum of 3 quarters · filed 2014-02-25
$29.34M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$8.68M
10-Q · filed 2013-05-08
$14.25M
derived: sum of 2 quarters · filed 2014-02-25
$19.88M
derived: sum of 3 quarters · filed 2014-02-25
$28.53M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$5.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$11.21M
derived: sum of 2 quarters · filed 2014-02-25
$19.86M
derived: sum of 3 quarters · filed 2014-02-25
$17.14M
10-K · filed 2014-02-25
2011-09-24$5.63M
10-Q · filed 2012-11-01
$14.28M
derived: sum of 2 quarters · filed 2012-11-01
$11.56M
10-Q · filed 2012-11-01
-$18.99M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-25$8.65M
10-Q · filed 2012-08-07
$5.93M
10-Q · filed 2012-08-07
-$24.62M
derived: sum of 3 quarters · filed 2013-02-27
-$7.95M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-26-$2.71M
10-Q · filed 2012-05-04
-$33.27M
derived: sum of 2 quarters · filed 2013-02-27
-$16.60M
derived: sum of 3 quarters · filed 2013-02-27
-$9.43M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-25-$30.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
-$13.88M
derived: sum of 2 quarters · filed 2013-02-27
-$6.71M
derived: sum of 3 quarters · filed 2013-02-27
$23.00K
10-K · filed 2013-02-27
2010-09-25$16.67M
10-Q · filed 2011-11-02
$16.30M
10-Q · filed 2010-11-04
$23.84M
derived: sum of 2 quarters · filed 2011-11-02
$30.58M
10-Q · filed 2011-11-02
$29.31M
10-Q · filed 2010-11-04
$40.24M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-26$7.17M
10-Q · filed 2011-08-03
$6.53M
10-Q · filed 2010-08-03
$13.91M
10-Q · filed 2011-08-03
$13.01M
10-Q · filed 2010-08-03
$23.57M
derived: sum of 3 quarters · filed 2012-02-27
$30.47M
derived: sum of 4 quarters · filed 2012-02-27
2010-03-27$6.74M
10-Q · filed 2011-05-04
$16.40M
derived: sum of 2 quarters · filed 2012-02-27
$23.30M
derived: sum of 3 quarters · filed 2012-02-27
$36.93M
derived: sum of 4 quarters · filed 2012-02-27
2009-12-26$9.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
$16.57M
derived: sum of 2 quarters · filed 2012-02-27
$30.20M
derived: sum of 3 quarters · filed 2012-02-27
$40.35M
10-K · filed 2012-02-27
2009-09-26$6.90M
10-Q · filed 2010-11-04
$20.53M
derived: sum of 2 quarters · filed 2010-11-04
$30.69M
10-Q · filed 2010-11-04
2009-06-27$13.63M
10-Q · filed 2010-08-03
$23.79M
10-Q · filed 2010-08-03
2008-12-27$57.03M
10-K · filed 2011-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71